Region: Denmark

Patent-backed rare disease innovations secure more M&A/licensing investment than any pharma assets outside oncology

07 September 2022

The launch of the new UPC will introduce markedly different changes to the patent landscape, but there are still many unknowns. Possible developments include increased opposition proceedings and third-party observations.

31 August 2022

While the broader implications of the introduction of a single European court tasked with handling patent matters are not yet clear, a look at the bigger picture suggests that demand for patent litigation looks set to increase.

11 May 2022

Danish company makes its biggest-ever acquisition in an area where demand for assets is growing rapidly

23 November 2021

Featured in IAM Global Leaders 2022

"I have experienced a change in client demands, specifically requiring more individualised services. Our clients’ knowledge of patent law has generally increased over the past two decades, and today more of our clients have an in house patent professional."

22 November 2021

Featured in IAM Global Leaders 2022

"In my practice, freedom-to-operate analyses, monitoring competitor rights and hence guiding companies in how to navigate through competitors’ patent rights have become everyday work."

22 November 2021

Featured in IAM Global Leaders 2022

"In my experience, it often makes sense to use analogies, in particular an analogy to something well known from our everyday life. By way of example, coagulation of proteins is very complex and difficult to explain in detail, but it helps to liken it to what happens when you boil an egg."

22 November 2021

Transfer of microfluidics tech comes as San Diego-based Illumina faces a fierce IP fight with an upstart Chinese rival

11 June 2019

Shenzhen BGI was once the biggest purchaser of Illumina’s gene sequencing machines. Now the two are on opposite sides of an expanding patent battle

28 May 2019

24 April 2019